HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer.
about
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivoAdenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.Optimizing Ventana chromogenic dual in-situ hybridization for mucinous epithelial ovarian cancer.A qualitative study comparing the assay performance characteristics between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 scoring methods in mucinous epithelial ovarian cancer.Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion.Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma.Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a systematic review and meta-analysis.The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies.Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.Recent Insights into Mucinous Ovarian Carcinoma.
P2860
Q33735170-E7E3012A-361A-42E0-BEB2-1B39669EA785Q34104079-4D25A415-B5E8-4D5E-9DD6-AFCAE89BF0E6Q34528553-F40A06E0-3376-4200-AF2F-E7E23BD44F43Q35076986-698EA19A-6142-4A65-8345-A400C97A2C14Q36152629-09D3511E-40F2-4C93-A6F3-0C8F351ED9C2Q37452255-86EB132E-6106-43CB-9B2C-60C91CD187A1Q37706043-00EA062C-A7CC-4839-BCD5-5D3BCD4624EFQ41042069-3AB27D03-28A6-497B-8AFB-0153B614CF6CQ45905776-BAB40AE7-3E83-4DA6-8E35-034B7028F496Q48141659-4E238E5E-B499-4615-895A-EA5E1D6E3129Q55286461-56994FEC-3364-4640-AAE3-D5A9B6DE6AC8Q55609057-8CE5F822-42AE-4A3B-A94D-98A242B783DD
P2860
HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@ast
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@en
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@nl
type
label
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@ast
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@en
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@nl
prefLabel
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@ast
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@en
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@nl
P2093
P2860
P1433
P1476
HER2 amplification and clinico ...... rare mucinous ovarian cancer.
@en
P2093
Cindy Pang
Inny Busmanis
John Whay-Kuang Chia
Kiat-Hon Lim
Lay-Tin Soh
Liang-Kee Goh
Lynette Ngo
Sharyl Thung
P2860
P304
P356
10.1371/JOURNAL.PONE.0061565
P407
P577
2013-04-19T00:00:00Z